Case File №
#VI-2026-0558
Shanghai Leader Peptide Biotechnology
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
39 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | B Good | 8 | 7.5 | 5.8 | 10.0 | 29 Dec 2025 |
| 5-amino-1MQ | X N/A | 1 | 8.6 | 8.6 | 8.6 | 11 Jun 2025 |
| AA Water | X N/A | 1 | 7.5 | 7.5 | 7.5 | 24 Apr 2025 |
| Alprostadil | X N/A | 1 | 5.9 | 5.9 | 5.9 | 6 May 2025 |
| Anavar (Oxandrolone) | X N/A | 1 | 7.5 | 7.5 | 7.5 | 13 Jun 2025 |
| Botulinum toxin | X N/A | 1 | 7.8 | 7.8 | 7.8 | 9 Jun 2025 |
| BPC-157 Arg Oral | X N/A | 1 | 7.2 | 7.2 | 7.2 | 2 Jul 2025 |
| Cardiogen | X N/A | 1 | 8.5 | 8.5 | 8.5 | 7 May 2025 |
| Cartalax | X N/A | 1 | 6.5 | 6.5 | 6.5 | 14 Jan 2025 |
| DHB (1-Test Cyp) | X N/A | 1 | 4.9 | 4.9 | 4.9 | 13 Jun 2025 |
| Dianabol Raw | X N/A | 1 | 7.3 | 7.3 | 7.3 | 11 Jun 2025 |
| Epithalon | X N/A | 1 | 7.6 | 7.6 | 7.6 | 28 Mar 2025 |
| GHRP-6 Acetate | X N/A | 1 | 6.6 | 6.6 | 6.6 | 25 Apr 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 7.6 | 7.6 | 7.6 | 2 Jul 2025 |
| Hexarelin | X N/A | 1 | 5.1 | 5.1 | 5.1 | 28 Mar 2025 |
| HGH Fragment 176-191 | X N/A | 1 | 8.1 | 8.1 | 8.1 | 3 Jul 2025 |
| IGF-1 LR3 | X N/A | 1 | 6.2 | 6.2 | 6.2 | 6 May 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 8.0 | 8.0 | 8.0 | 28 Mar 2025 |
| Pancragen | X N/A | 1 | 7.9 | 7.9 | 7.9 | 8 Jul 2025 |
| PEG MGF | X N/A | 1 | 8.5 | 8.5 | 8.5 | 8 Jul 2025 |
| Phenylacetic acid CAS 103-82-2 | X N/A | 1 | 8.5 | 8.5 | 8.5 | 6 May 2025 |
| PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | X N/A | 1 | 9.0 | 9.0 | 9.0 | 27 Feb 2025 |
| Prostamax | X N/A | 1 | 9.6 | 9.6 | 9.6 | 11 Jun 2025 |
| PTD-DBM | X N/A | 1 | 7.8 | 7.8 | 7.8 | 25 Apr 2025 |
| Retatrutide 5mg + Cagrilintide 5mg Blend | X N/A | 1 | 8.7 | 8.7 | 8.7 | 17 Dec 2024 |
| Romosozumab | X N/A | 1 | 4.7 | 4.7 | 4.7 | 6 May 2025 |
| Sildenafil Raw | X N/A | 1 | 6.7 | 6.7 | 6.7 | 25 Apr 2025 |
| Supertest 450 | X N/A | 1 | 10.0 | 10.0 | 10.0 | 28 Mar 2025 |
| T4 (Levothyroxine) | X N/A | 1 | 8.6 | 8.6 | 8.6 | 6 May 2025 |
| Teriparatide | X N/A | 1 | 7.6 | 7.6 | 7.6 | 27 Feb 2025 |
| Test Enanthate | X N/A | 1 | 5.8 | 5.8 | 5.8 | 9 Jun 2025 |
| Test Undecanoate | X N/A | 1 | 9.0 | 9.0 | 9.0 | 28 Mar 2025 |
| Testosterone Decanoate Raw | X N/A | 1 | 8.0 | 8.0 | 8.0 | 11 Jun 2025 |
| Testosterone Propionate Raw | X N/A | 1 | 8.5 | 8.5 | 8.5 | 21 May 2025 |
| Thymalin | X N/A | 1 | 8.9 | 8.9 | 8.9 | 27 Feb 2025 |
| Tren Base | X N/A | 1 | 7.5 | 7.5 | 7.5 | 14 Jan 2025 |
| Tren Hex | X N/A | 1 | 8.6 | 8.6 | 8.6 | 20 Jun 2025 |
| TriTren 225 | X N/A | 1 | 6.3 | 6.3 | 6.3 | 8 Jul 2025 |
| Turinabol | X N/A | 1 | 7.4 | 7.4 | 7.4 | 20 Jun 2025 |
Exhibit II
Evidence Log
45 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | Testosterone Propionate Raw | 10.0 A | 5g | 4.3g | -14.9% | 97.26% | h2fkh4 | Lab C | Public |
| 24 May 2026 | Alprostadil | 8.3 A | 2mg | 1.8mg | -8.9% | 95.31% | wsbz77 | Lab G | Public |
| 24 May 2026 | Botulinum toxin | 8.4 A | 20mg | 22.4mg | +12.2% | 96.77% | 0r0qjt | Lab A | Community |
| 24 May 2026 | Cartalax | 6.5 A | 30mg | 35.3mg | +17.7% | 96.16% | e6at9m | Lab E | Public |
| 24 May 2026 | GHRP-6 Acetate | 6.4 A | 2mg | 1.8mg | -11.8% | 98.84% | sor90o | Lab F | Community |
| 24 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 8.2 A | 15mg | 17.9mg | +19.7% | 97.26% | l4h0i6 | Lab F | Public |
| 24 May 2026 | Phenylacetic acid CAS 103-82-2 | 9.8 A | 1g | 1.2g | +20.3% | 99.40% | 0wd1f5 | Lab B | Community |
| 24 May 2026 | Testosterone Decanoate Raw | 8.6 A | 10g | 8.5g | -14.8% | 96.96% | z2xssz | Lab C | Community |
| 24 May 2026 | Tren Base | 7.6 A | 300mg/ml | 319.9mg/ml | +6.6% | 98.35% | 2vdnu4 | Lab D | Public |
| 24 May 2026 | IGF-1 LR3 | 5.4 B | 50mg | 52.2mg | +4.4% | 99.58% | v0nrg7 | Lab C | Public |
| 24 May 2026 | PEG MGF | 10.0 A | 2mg | 2.4mg | +21.0% | 97.18% | fnvb06 | Lab A | Public |
| 24 May 2026 | Thymalin | 8.5 A | 30mg | 28.4mg | -5.4% | 97.89% | 69k1ay | Lab B | Public |
| 23 May 2026 | Retatrutide | 8.0 A | 20mg | 20.1mg | +0.5% | 99.90% | (no batch ID) | Lab E | Public |
| 23 May 2026 | 5-amino-1MQ | 8.6 A | 50mg | 59.3mg | +18.5% | 98.87% | u6x8j2 | Lab B | Public |
| 23 May 2026 | Hexarelin | 4.4 C | 30mg | 29.6mg | -1.4% | 97.17% | a8d2ab | Lab A | Community |
| 23 May 2026 | AA Water | 7.2 A | 5mg | 4.7mg | -5.4% | 98.78% | yx50is | Lab C | Public |
| 23 May 2026 | PTD-DBM | 8.6 A | 10mg | 11.0mg | +10.2% | 96.79% | 60guw3 | Lab F | Community |
| 22 May 2026 | Retatrutide | 6.5 B | 20mg | 21.7mg | +8.5% | 99.74% | (no batch ID) | Lab E | Public |
| 21 May 2026 | Retatrutide | 7.8 A | 10mg | 9.8mg | -2.0% | 99.80% | (no batch ID) | Lab G | Public |
| 20 May 2026 | BPC-157 Arg Oral | 5.4 B | 10mg | 11.6mg | +16.0% | 96.15% | 2blgsq | Lab A | Public |
| 20 May 2026 | Epithalon | 7.9 A | 10mg | 10.8mg | +8.4% | 96.73% | hbw53k | Lab B | Community |
| 20 May 2026 | Pancragen | 7.5 A | 20mg | 22.5mg | +12.7% | 99.95% | ezqss8 | Lab E | Community |
| 20 May 2026 | T4 (Levothyroxine) | 8.3 A | 50mg | 51.7mg | +3.3% | 96.43% | 9ejr7j | Lab B | Public |
| 20 May 2026 | Teriparatide | 8.3 A | 15mg | 14.5mg | -3.5% | 96.23% | ocaikl | Lab D | Community |
| 19 May 2026 | Retatrutide | 6.4 B | 20mg | 22.1mg | +10.5% | 99.90% | (no batch ID) | Lab E | Public |
| 19 May 2026 | Retatrutide | 6.0 B | 30mg | 33.7mg | +12.3% | 99.90% | (no batch ID) | Lab E | Public |
| 17 May 2026 | Prostamax | 9.7 A | 50mg | 59.6mg | +19.1% | 98.83% | dnlgcz | Lab F | Community |
| 29 Jan 2026 | Turinabol | 8.0 A | 50mg | 42.7mg | -14.7% | 98.32% | ko3j0l | Lab D | Community |
| 26 Jan 2026 | Retatrutide | 5.8 C | 10mg | 11.2mg | +12.0% | 99.80% | (no batch ID) | Lab E | Public |
| 26 Jan 2026 | Cardiogen | 10.0 A | 20mg | 19.8mg | -1.1% | 96.63% | te9sn6 | Lab G | Community |
| 26 Jan 2026 | Dianabol Raw | 7.2 A | 5g | 4.8g | -4.3% | 96.36% | l0c5jk | Lab A | Community |
| 19 Jan 2026 | Test Enanthate | 5.5 B | 200mg/ml | 203.8mg/ml | +1.9% | 99.40% | t74aj0 | Lab B | Community |
| 9 Jan 2026 | Test Undecanoate | 9.0 A | 300mg/ml | 313.5mg/ml | +4.5% | 97.17% | wt18hu | Lab A | Community |
| 29 Dec 2025 | Retatrutide | 10.0 A | 15mg | 15.2mg | +1.3% | 99.95% | 14 | Lab E | Public |
| 29 Dec 2025 | Romosozumab | 4.0 C | 30mg | 37.3mg | +24.2% | 95.66% | pr6q2t | Lab G | Community |
| 5 Dec 2025 | TriTren 225 | 6.3 A | 250mg/ml | 301.6mg/ml | +20.6% | 97.55% | 422orc | Lab C | Community |
| 23 Nov 2025 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 9.0 A | 50mg | 42.8mg | -14.5% | 96.10% | pgbgxj | Lab F | Public |
| 14 Nov 2025 | Sildenafil Raw | 6.4 A | 10g | 8.6g | -14.3% | 95.74% | ndoc8z | Lab G | Community |
| 5 Nov 2025 | Anavar (Oxandrolone) | 8.9 A | 50mg | 62.1mg | +24.2% | 98.71% | q1kmbg | Lab C | Community |
| 5 Nov 2025 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 9.0 A | 100g | 91.9g | -8.1% | 96.08% | xc0xty | Lab A | Community |
| 4 Nov 2025 | Tren Hex | 7.8 A | 200mg/ml | 183.5mg/ml | -8.3% | 96.64% | 5yvptx | Lab D | Public |
| 17 Oct 2025 | DHB (1-Test Cyp) | 4.0 C | 100mg/ml | 106.8mg/ml | +6.8% | 98.23% | 2buoxo | Lab E | Public |
| 9 Oct 2025 | Retatrutide 5mg + Cagrilintide 5mg Blend | 6.6 A | 50mg | 46.5mg | -6.9% | 99.10% | dwl70b | Lab E | Public |
| 9 Oct 2025 | Supertest 450 | 9.8 A | 100mg/ml | 116.2mg/ml | +16.2% | 98.95% | xwvbe0 | Lab B | Public |
| 3 Oct 2025 | HGH Fragment 176-191 | 9.2 A | 20mg | 22.2mg | +11.2% | 95.53% | wzdlix | Lab A | Public |
— END OF EVIDENCE LOG —